192 related articles for article (PubMed ID: 9142733)
1. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.
Fukuoka S; Hayashida K; Hirose Y; Shimotsu Y; Ishida Y; Kakuchi H; Eto T
Eur J Nucl Med; 1997 May; 24(5):523-9. PubMed ID: 9142733
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
[TBL] [Abstract][Full Text] [Related]
3. [Prediction of effect of beta-blocker therapy in patients with dilated cardiomyopathy by using 123I-BMIPP, 123I-MIBG scintigraphy].
Inoue A; Yamazaki J; Nanjou S; Togane Y; Amano H
Kaku Igaku; 2001 Mar; 38(2):99-104. PubMed ID: 11345771
[TBL] [Abstract][Full Text] [Related]
4. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.
Suwa M; Otake Y; Moriguchi A; Ito T; Hirota Y; Kawamura K; Adachi I; Narabayashi I
Am Heart J; 1997 Mar; 133(3):353-8. PubMed ID: 9060806
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of beta-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis.
Fujimoto S; Inoue A; Hisatake S; Yamashina S; Yamashina H; Nakano H; Yamazaki J
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1356-61. PubMed ID: 15221293
[TBL] [Abstract][Full Text] [Related]
6. Quantitative scintigraphic analysis of 123I-MIBG by polar map in patients with dilated cardiomyopathy.
Yamazaki J; Muto H; Ishiguro S; Okamoto K; Hosoi H; Nakano H; Morishita T
Nucl Med Commun; 1997 Mar; 18(3):219-29. PubMed ID: 9106775
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
[TBL] [Abstract][Full Text] [Related]
8. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
Wakita T; Numata Y; Ogata Y; Harada E; Mizumasa Y
J Cardiol; 1995 Sep; 26(3):177-83. PubMed ID: 7473048
[TBL] [Abstract][Full Text] [Related]
10. The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy.
Inoue A; Yamashina S; Yamazaki J
Ann Nucl Med; 2003 Dec; 17(8):677-83. PubMed ID: 14971610
[TBL] [Abstract][Full Text] [Related]
11. Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Suzuki T; Kurabayashi M
Chest; 2002 Aug; 122(2):542-8. PubMed ID: 12171829
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of 123I-MIBG scintigraphy for prediction of effect of beta-blocker therapy in dilated cardiomyopathy].
Tawarahara K; Sugiyama T; Nakano T; Matou F; Kurata C; Wakabayashi Y; Shouda S; Mikami T
Kaku Igaku; 1998 Jul; 35(6):413-20. PubMed ID: 9753920
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of dilated cardiomyopathy with the relationship between the effect of beta-blocker therapy and the changes of myocardial clearance of 123I-metaiodobenzylguanidine].
Momose M; Kobayashi H; Saito K; Horie T; Maki M; Hosoda S; Kusakabe K
Kaku Igaku; 1995 Mar; 32(3):301-6. PubMed ID: 7739160
[TBL] [Abstract][Full Text] [Related]
14. [Clinical meaning of 123I-MIBG myocardial SPeCT in patients with dilated cardiomyopathy].
Yamazaki J; Hosoi H; Yamashina H; Kabano T; Yamashina S; Nanjo S; Matsukawa S; Morishita T; Okamoto K; Ohsawa H
Kaku Igaku; 1994 Apr; 31(4):373-7. PubMed ID: 8196234
[TBL] [Abstract][Full Text] [Related]
15. [Serial assessment of MIBG scintigraphy in a case of DCM with heart failure improved by beta-blocker therapy].
Yamamoto K; Asada S; Yabunouchi T; Morozumi R; Kusuoka H; Nishimura T
Kaku Igaku; 1995 Apr; 32(4):413-8. PubMed ID: 7776548
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
[TBL] [Abstract][Full Text] [Related]
17. Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy.
Yamakado K; Takeda K; Kitano T; Nakagawa T; Futagami Y; Konishi T; Hamada M; Nakano T; Ichihara T
Eur J Nucl Med; 1992; 19(4):265-70. PubMed ID: 1597243
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment.
Kakuchi H; Sasaki T; Ishida Y; Komamura K; Miyatake K
Heart; 1999 Feb; 81(2):148-52. PubMed ID: 9922349
[TBL] [Abstract][Full Text] [Related]
19. Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Nakata S; Shigematsu Y
Circ J; 2002 Dec; 66(12):1139-43. PubMed ID: 12499621
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
